For Q2, according to Seeking Alpha, analysts are expecting normalized EPS of $1.28, GAAP EPS of $0.97, and $12.52bn of ...

The BlackRock Health Sciences Opportunities Fund posted returns of -4.56% (Institutional shares) and -4.62% (Investor A shares, without sales charge) for the first quarter of 2026. During the quarter, ...

(Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company focused on the development and commercialization of scalable microbial protein production ...

As life sciences companies navigate the complexities of new market entry and critical regulatory milestones, strategic guidance is essential for successful expansion and compliance. To support these ...

Executives report they are prioritizing growth discipline, AI value proof and resilience in the second half of 2026 NEW YORK, June 25, 2026 /PRNewswire/ -- Life sciences executives report they are ...

Join us for an in‑depth Masterclass that unpacks one of the most influential—and often misunderstood—elements of health ...

Harvard College will be reorganized into five umbrella groups — dismantling the Office of Student Services and reviving the ...

Detailed price information for Phio Pharmaceuticals Corp (PHIO-Q) from The Globe and Mail including charting and trades.

Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen’s Virginia Gas ProjectListing expected ...

TRICARE, the military’s healthcare program, limits coverage of applied behavior analysis, a type of therapy for people with ...

Duke plans to welcome 90 transfer students this fall, with 82 enrolling in the Trinity College of Arts & Sciences and eight ...

C1 Monoclonal Antibody Progress for RSV and Malaria Following Full $3.1 Million Gates Foundation Grant FundingJUPITER, Fla., July 07, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ...